Homepage - JADPRO

For updated information about JADPRO Live 2023, please visit JADPROLive.com

For information about the JADPRO Workshop, please visit JADPROworkshop.com

CURRENT ISSUE Current Issue Cover

VOL 14 NO 4 • May/Jun 2023

IN THIS ISSUE

Tips for Writing a Research Protocol

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia

Sara M. Tinsley-Vance, PhD, APRN, AOCN®

Distress in Neuro-Oncology Patients and Its Implications for Communication

Carolin Roos,(1) Johannes Weller,(1) MD, Christiane Landwehr,(1) Anja Sciermoch,(2) Cathrina Duffy,(1) MD, Karoline Kohlmann,(1) MD, Christina Schaub,(1) MD, Theophilos Tzaridis,(1) MD, Matthias Schneider,(2) MD, Patrick Schuss,(2) MD, Ulrich Herrlinger,(1) MD, and Niklas Schäfer,(1) MD

Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin

Rebecca Lu, MSN, FNP-C, Ashley Morphey, RN, MSN, CCRP, FelIcia Diaz, MSN, APRN, FNP-BC, AOCNP®, Jessica Chen, RN, MSN, OCN®, FNP-C, Azadeh Razmandi, OD, FAAO, and Tiffany Richards, PhD, ANP-BC, AOCNP®

Tak W. Mak, PhD, FAACR, Selected for 202...

Tak W. Mak, PhD, FAACR, was recently announced as...

Polatuzumab Vedotin-piiq for Previously ...

On April 19, 2023, polatuzumab vedotin-piiq was ap...

Addressing Racial Disparities in Cancer ...

Guest Editor’s Note: Despite its high prevalence, ...

Interruption of Endocrine Therapy to Att...

In a study reported in The New England Journal of ...

More News From Today

EDITORIALS & COMMENTARY

Advanced Practitioners as Allies and Advocates

Advanced practitioners (APs) are a growing proportion of the health-care team...

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO Twitter Feed.cshtml)

More Tweets

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.